Sources, in the open.

How we approach the evidence

We prioritize regulators, medical societies, original human clinical studies and university health systems. We include conflicting findings and distinguish clinical evidence from expert consensus. This is a selected educational collection, not a systematic review.

Older landmark studies and current guidance can both be useful; publication dates are identified rather than presented as new research. FDA approvals are product- and indication-specific. Older broad statements about cell approvals must be read alongside the current FDA product list.

Content is not independently medically reviewed by a RegenLuma clinician. Clinical review and confirmed clinic details are needed before this content is used for patient-specific recommendations. Sources do not imply endorsement, affiliation or a treatment offering.

We link to original publications instead of reproducing their full papers or protected figures. Downloadable RegenLuma guides are original patient-education summaries with references. Illustrations are explanatory and not to scale; photography is illustrative.